Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy

Thumbnail Image

Files

1-s2.0-S002839082500512X-main.pdf (5.19 MB)
Identifiers
URI: https://hdl.handle.net/20.500.12614/4163
DOI: 10.1016/j.neuropharm.2025.110804

Date

2026
Export

Journal ISSN

Volume Title

Publisher

Citations
Google Scholar

Authors

Supervisors

Journal Title

Neuropharmacology

Description

Awarding university

Methods and software necessary to open the files

Patent number

Funding

Research Projects

Organizational Units

Journal Issue

Abstract

Keywords

Citation

Collections

Publications